Teachers Advisors’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-46,562
| Closed | -$1.01M | – | 3128 |
|
|
2017
Q2 | $1.01M | Buy |
46,562
+2,671
| +6% | +$48.5K | ﹤0.01% | 2230 |
|
|
2017
Q1 | $616K | Buy |
43,891
+1,975
| +5% | +$32.3K | ﹤0.01% | 2429 |
|
|
2016
Q4 | $786K | Buy |
41,916
+198
| +0.5% | +$3.37K | ﹤0.01% | 2306 |
|
|
2016
Q3 | $689K | Hold |
41,718
| – | – | ﹤0.01% | 2295 |
|
|
2016
Q2 | $561K | Buy |
41,718
+5,943
| +17% | +$86.7K | ﹤0.01% | 2352 |
|
|
2016
Q1 | $547K | Hold |
35,775
| – | – | ﹤0.01% | 2298 |
|
|
2015
Q4 | $710K | Hold |
35,775
| – | – | ﹤0.01% | 2204 |
|
|
2015
Q3 | $623K | Hold |
35,775
| – | – | ﹤0.01% | 2260 |
|
|
2015
Q2 | $723K | Buy |
35,775
+2,524
| +8% | +$48.7K | ﹤0.01% | 2306 |
|
|
2015
Q1 | $585K | Hold |
33,251
| – | – | ﹤0.01% | 2345 |
|
|
2014
Q4 | $541K | Hold |
33,251
| – | – | ﹤0.01% | 2401 |
|
|
2014
Q3 | $734K | Hold |
33,251
| – | – | ﹤0.01% | 2176 |
|
|
2014
Q2 | $669K | Sell |
33,251
-2,348
| -7% | -$39.8K | ﹤0.01% | 2281 |
|
|
2014
Q1 | $662K | Hold |
35,599
| – | – | ﹤0.01% | 2238 |
|
|
2013
Q4 | $359K | Buy |
35,599
+3,020
| +9% | +$36.5K | ﹤0.01% | 2557 |
|
|
2013
Q3 | $420K | Buy |
32,579
+1,943
| +6% | +$23.9K | ﹤0.01% | 2429 |
|
|
2013
Q2 | $364K | Buy |
+30,636
| New | +$332K | ﹤0.01% | 2421 |
|
Other funds holding AMRI
Teachers Advisors's AMRI Position: Q3 2017 in Review
Teachers Advisors sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 46,562 shares — an estimated $1.01M sold.
Teachers Advisors first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $1.01M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.
- Teachers Advisors reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
- Teachers Advisors sold 46,562 Albany Molecular Research Inc shares in Q3 2017, an estimated $1.01M.
- Teachers Advisors first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
- Teachers Advisors's Albany Molecular Research Inc position peaked at $1.01M in Q2 2017.
- 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.
Based on Teachers Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.